Aytu Biopharma (AYTU) Treasury Shares (2018 - 2026)
Aytu Biopharma's (AYTU) quarterly Treasury Shares came in at $220300.0 in Q1 2026, up 538.03% year-on-year from $34528.0 in Q1 2025, and up 5507400.0% on a QoQ basis from $4.0 in Q4 2025.
Aytu Biopharma (AYTU) Treasury Shares (2018 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 9 years of Treasury Shares data on file, last reported at $220300.0 in Q1 2026.
- On a quarterly basis, Treasury Shares rose 538.03% year-over-year to $220300.0 in Q1 2026; TTM through Mar 2026 was $220300.0, a 538.03% increase from a year earlier, with the FY2025 full-year figure at $32912.0, up 36.54% from the prior year.
- Treasury Shares for Q1 2026 stood at $220300.0, up from $4.0 in the prior quarter.
- Over the last five years, Treasury Shares for AYTU reached as high as $2.1 million in Q1 2022 and fell as low as $4.0 in Q4 2025.
- Historically, Treasury Shares has averaged $167067.1 across 5 years, with a median of $37929.0 in 2023.
- Across the five-year window, Treasury Shares soared 119579.79% in 2022 and sank 99.29% in 2025, its largest moves.
- Year by year, Treasury Shares stood at $43276.0 in 2022, then fell by 12.36% to $37929.0 in 2023, then tumbled by 98.51% to $565.0 in 2024, then sank by 99.29% to $4.0 in 2025, then jumped by 5507400.0% to $220300.0 in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $220300.0 in Q1 2026, $4.0 in Q4 2025, and $31294.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Aytu Biopharma | 1.43 Mn | -25.28 Mn | 7.60 Mn | 220,300.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 220,300.00 |
| Mar 31, 2026 | 220,300.00 |
| Dec 31, 2025 | 4.00 |
| Dec 31, 2025 | 4.00 |
| Sep 30, 2025 | 31,294.00 |
| Sep 30, 2025 | 31,294.00 |
| Jun 30, 2025 | 32,912.00 |
| Jun 30, 2025 | 32,912.00 |
| Mar 31, 2025 | 34,528.00 |
| Mar 31, 2025 | 34,528.00 |
| Dec 31, 2024 | 565.00 |
| Dec 31, 2024 | 565.00 |
| Sep 30, 2024 | 838.00 |
| Sep 30, 2024 | 838.00 |
| Jun 30, 2024 | 24,105.00 |
| Jun 30, 2024 | 24,105.00 |
| Mar 31, 2024 | 2,336.00 |
| Mar 31, 2024 | 2,336.00 |
| Dec 31, 2023 | 37,929.00 |
| Dec 31, 2023 | 37,929.00 |